qordata Adds 2015 Open Payments Data to Its Open Payments Analytics Software
Princeton, New Jersey, August 10, 2016 (Newswire.com) - With the 2015 data and new dashboards, pharmaceutical manufacturers and GPO’s will have the ability to determine FMV, spot outliers, detect off label & transparency reporting errors, analyze spend data and have real analytics in place, identify spend data discrepancies and mitigate FCA and anti-kickback statute.
According to Zafar Ahmed, Head of Marketing at qordata, “With the 2015 data now available, compliance departments can now empower the entire organization with a live interactive dashboard of their 2015 spend data and give a retrospective analysis of their data.”
"With the 2015 data now available, compliance departments can now empower the entire organization with a live interactive dashboard of their 2015 spend data and give a retrospective analysis of their data."
Zafar Ahmed, Head of Marketing
The new data comes with new and revamped dashboards to add value to compliance and marketing functions. These include:
- Executive Summary
- Spend by Physician
- Spend by Hospital
- Spend by Type & Period
- Spend by Geography
- Spend Outliers
- Company Spend Summary
About qordata: qordata software solutions to pharmaceutical companies to help them get more out of their open payments data and to ensure that it complies with all data submission requirements set by the CMS. qordata’s core competencies and expertise lie in data analytics, integration, master data management and big data.
Source: qordata.com
Share:
Tags: biotech, medical devices, open payments, open payments data, pharmaceutical